Producer in China; Tacrolimus; CAS: 104987-11-3

DKY hundred years specializing in the production of bulk drug manufacturers, the company is committed to chemical raw materials intermediates, biomedical technology as the core of the production, research and development.
Has hundreds of domestic and foreign major pharmaceutical manufacturers and research institutes to establish a stable and good relations of cooperation.
Welcome to business enterprises to negotiate business, hand in hand a total of raw materials industry peak.


Product Name:    Tacrolimus

CAS:    104987-11-3
MF:    C44H69NO12
MW:    804.02

Melting point     113-115°C
storage temp.     −20°C
solubility     DMSO: >3 mg/mL
form     solid
color     white
Purity: 99%
Storage: Shading, Confined Preservation
Delivery: by DHL, TNT, FedEx, Hkems, UPS, etc.
Specification: USP
HS Code: 15347069687
 


Chemical Properties    White Crystalline Solid
Usage    An immunosuppressant that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2. Shown to inhibit the activity of FK-506 binding protein, thereby reversing its effects on sarcoplasmic reticulum Ca+2 release.
Usage    FK-506 (Tacrolimus) is a macrolide immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient's immune system
Usage    Tacrolimus (fujimycin) was discovered as a potent inhibitor of IL2 production in a targeted search for novel immunosuppressants. Tacrolimus acts by blocking T cell proliferation in vitro by inhibiting the generation of several lymphokines, notably the original target IL-2. Tacrolimus inhibits the activity of FK-506 binding protein, Ca2+-dependent phosphatase and calcineurin, and activates NF-κB through phosphorylation and degradation of IκBα.
Usage    treatment of Cushing's syndrome
Usage    For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was first approved by the FDA in 1994 for use in liver transplantation, this has been extended to include kidney, heart,
.
  DKY hundred years specializing in the production of bulk drug manufacturers, the company is committed to chemical raw materials intermediates, biomedical technology as the core of the production, research and development.
Has hundreds of domestic and foreign major pharmaceutical manufacturers and research institutes to establish a stable and good relations of cooperation.
Welcome to business enterprises to negotiate business, hand in hand a total of raw materials industry peak.


Product Name:    Tacrolimus

CAS:    104987-11-3
MF:    C44H69NO12
MW:    804.02

Melting point     113-115°C
storage temp.     −20°C
solubility     DMSO: >3 mg/mL
form     solid
color     white
Purity: 99%
Storage: Shading, Confined Preservation
Delivery: by DHL, TNT, FedEx, Hkems, UPS, etc.
Specification: USP
HS Code: 15347069687
 


Chemical Properties    White Crystalline Solid
Usage    An immunosuppressant that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2. Shown to inhibit the activity of FK-506 binding protein, thereby reversing its effects on sarcoplasmic reticulum Ca+2 release.
Usage    FK-506 (Tacrolimus) is a macrolide immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient's immune system
Usage    Tacrolimus (fujimycin) was discovered as a potent inhibitor of IL2 production in a targeted search for novel immunosuppressants. Tacrolimus acts by blocking T cell proliferation in vitro by inhibiting the generation of several lymphokines, notably the original target IL-2. Tacrolimus inhibits the activity of FK-506 binding protein, Ca2+-dependent phosphatase and calcineurin, and activates NF-κB through phosphorylation and degradation of IκBα.
Usage    treatment of Cushing's syndrome
Usage    For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was first approved by the FDA in 1994 for use in liver transplantation, this has been extended to include kidney, heart,
.
 

Pain Relief Patch For Breast

Pain Relief Patch for Breast
[Name] Medical Cold Patch
[Package Dimension] 10 round pieces
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application] For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for breast hyperplasia, breast fibroids, mastitis, breast agglomera tion, swollen pain.
[How To Use a Patch]
Please follow the Schematic Diagram. One piece, one time.
The curing effect of each piece can last for 6-8 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions]
Store below 30c in a dry place away from heat and direct sunlight.

Pain Relief Patch For Breast,Pain Relief Plaster For Breast,Relief For Breast Pain,Pad Relief Patch For Breast

Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.xijieyitongpatches.com